Intrinsic Value of S&P & Nasdaq Contact Us

Geron Corporation GERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.89
+248.5%

Stock Statistics — GERN

Geron Corporation (GERN) has a market capitalization of $1.08B and trades at $1.69. The 52-week range is 1.04-2.01.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13, Earnings Per Share (EPS) of $-0.13, annual revenue of $183.88M.

The stock has a beta of 0.67, operates in the Healthcare sector.

Trading Data
Current Price$1.69
52-Week Range1.04-2.01
Volume20.93M
Avg Volume (30D)22.67M
Market Cap$1.08B
Beta (1Y)0.67
Company
IPO Date1996-07-31
Employees229
CEOHarout Semerjian
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS3741631036
CUSIP374163103
Income (Latest Year)
Revenue$183.88M
Gross Profit$179.14M
EBITDA$-51.92M
Operating Income$-53.84M
Net Income$-85.78M
EPS$-0.13
EPS Diluted$-0.13
Shares Outstanding$666.66M
Balance Sheet (Latest Year)
Total Assets$570.54M
Current Assets$520.27M
Cash & ST Investments$359.8M
Total Liabilities$344.67M
Total Debt$251.57M
Net Debt$172.13M
Total Equity$225.87M
Debt / Equity1.11
Valuation Ratios
P/E Ratio-13
P/S Ratio5.89
P/B Ratio4.79
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message